SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-024673
Filing Date
2021-02-17
Accepted
2021-02-17 08:07:02
Documents
13
Period of Report
2021-02-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm216978d1_8k.htm   iXBRL 8-K 30439
2 EXHIBIT 99.1 tm216978d1_ex99-1.htm EX-99.1 14125
  Complete submission text file 0001104659-21-024673.txt   222755

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA avdl-20210215.xsd EX-101.SCH 3181
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE avdl-20210215_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avdl-20210215_pre.xml EX-101.PRE 22707
6 EXTRACTED XBRL INSTANCE DOCUMENT tm216978d1_8k_htm.xml XML 3473
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37977 | Film No.: 21642700
SIC: 2834 Pharmaceutical Preparations